Results 31 to 40 of about 4,028,312 (182)

Distribution pattern of amino acid mutations in chloroquine and antifolate drug resistance associated genes in complicated and uncomplicated Plasmodium vivax isolates from Chandigarh, North India

open access: yesBMC Infectious Diseases, 2020
Background The increasing antimalarial drug resistance is a significant hindrance to malaria control and elimination programs. For the last six decades, chloroquine (CQ) plus pyrimethamine remains the first-line treatment for P. vivax malaria.
Hargobinder Kaur   +7 more
doaj   +1 more source

High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. [PDF]

open access: yes, 2009
BACKGROUND: Sulphadoxine-pyrimethamine (SP) a widely used treatment for uncomplicated malaria and recommended for intermittent preventive treatment of malaria in pregnancy, is being investigated for intermittent preventive treatment of malaria in infants
Gesase Samwel   +54 more
core   +2 more sources

The Impact of Antimalarial Use on the Emergence and Transmission of Plasmodium falciparum Resistance: A Scoping Review of Mathematical Models

open access: yesTropical Medicine and Infectious Disease, 2017
The emergence and transmission of resistance to antimalarial treatments continue to hamper malaria elimination efforts. A scoping review was undertaken regarding the impact of antimalarial treatment in the human population on the emergence and ...
Aleisha R. Brock   +3 more
doaj   +1 more source

Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children. [PDF]

open access: yes, 2008
BACKGROUND: Use of different methods for assessing the efficacy of artemisinin-based combination antimalarial treatments (ACTs) will result in different estimates being reported, with implications for changes in treatment policy.
Pinoges Loretxu   +55 more
core   +1 more source

Quality of antimalarial drugs and antibiotics in Papua New Guinea : a survey of the health facility supply chain [PDF]

open access: yes, 2014
Poor-quality life-saving medicines are a major public health threat, particularly in settings with a weak regulatory environment. Insufficient amounts of active pharmaceutical ingredients (API) endanger patient safety and may contribute to the ...
Betuela Inoni   +40 more
core   +2 more sources

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery

open access: yesInfection and Drug Resistance, 2020
Melkamu Adigo Shibeshi, Zemene Demelash Kifle, Seyfe Asrade Atnafie Department of Pharmacology, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence: Zemene Demelash KifleDepartment of ...
Shibeshi MA, Kifle ZD, Atnafie SA
doaj  

Drug resistant falciparum malaria and the use of artesunate-based combinations : focus on clinical trials sponsored by TDR [PDF]

open access: yesJournal of Vector Borne Diseases, 2003
Antimalarial drug resistance has now become a serious global challenge and is the principal reasonfor the decline in antimalarial drug efficacy. Malaria endemic countries need inexpensive and efficaciousdrugs.
Walter R.J. Taylor, Jean Rigal & Piero L. Olliaro
doaj  

A database of antimalarial drug resistance

open access: yesMalaria Journal, 2006
A large investment is required to develop, license and deploy a new antimalarial drug. Too often, that investment has been rapidly devalued by the selection of parasite populations resistant to the drug action.
Ringwald Pascal, Sibley Carol
doaj   +1 more source

Inhibitors of the Plasmodium falciparum Hsp90 towards Selective Antimalarial Drug Design: The Past, Present and Future

open access: yesCells, 2021
Malaria is still one of the major killer parasitic diseases in tropical settings, posing a public health threat. The development of antimalarial drug resistance is reversing the gains made in attempts to control the disease.
Melissa Louise Stofberg   +3 more
doaj   +1 more source

Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance. [PDF]

open access: yes, 2007
BACKGROUND\ud \ud Intermittent preventive treatment (IPT) is a promising intervention for malaria control, although there are concerns about its impact on drug resistance.\ud \ud METHODS\ud \ud The key model inputs are age-specific values for a) baseline
Sutherland Colin   +18 more
core   +1 more source

Home - About - Disclaimer - Privacy